Alexander R. Coltoff

Alexander R. Coltoff

Hematology Oncology | Hematology | Oncology

86 Jonathan Lucas St
2nd Floor, 3rd Floor
Charleston, SC 29425

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Management of inherited fibrinogen disorder during chemotherapy and allogeneic stem cell transplant.

Management of inherited fibrinogen disorder during chemotherapy and allogeneic stem cell transplant.

Journal: BMJ case reports

Published: June 02, 2026

Antigen-directed p53 restoration in TP53-mutated myeloid neoplasms: a hypothesis and theory perspective.

Antigen-directed p53 restoration in TP53-mutated myeloid neoplasms: a hypothesis and theory perspective.

Journal: Frontiers in oncology

Published: May 06, 2026

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

Journal: Leukemia

Published: May 05, 2026

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Journal: Leukemia & lymphoma

Published: April 09, 2026

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia.

Journal: Hematological oncology

Published: January 23, 2026

Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia.

Clinical utility of interim bone marrow biopsies in FLT3 mutant acute myeloid leukemia.

Journal: Leukemia research

Published: September 10, 2025

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Journal: Blood advances

Published: August 06, 2025

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias.

Journal: Blood advances

Published: August 06, 2025

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Journal: Blood cancer journal

Published: July 01, 2025

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Journal: Blood cancer journal

Published: June 08, 2025

Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis.

Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis.

Journal: Blood advances

Published: April 29, 2025

Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.

Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.

Journal: British journal of haematology

Published: February 13, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026